Webcast and Presentations

Throughout the year, Depomed presents at numerous conferences to help ensure investors are kept apprised of recent company developments. The following is a list of the conference Depomed is scheduled to attend in the coming weeks as well as upcoming corporate events, including quarterly earnings conference calls.

Upcoming Events
DateTitleRemind MePrior to Event
02/27/18
1:30 p.m. PT
Q4 2017 Depomed Earnings Conference Call
Supporting Materials
days
Enter your e-mail address 
Archived Webcasts
DateTitle
02/22/18
11:30 a.m. ET
Depomed at 2018 RBC Capital Markets Global Healthcare Conference
02/14/18
2:00 p.m. ET
Depomed at LEERINK Partners 7th Annual Global Healthcare Conference
12/05/17
10:30 a.m. ET
Depomed Conference Call to Discuss NUCYNTA® Commercialization Agreement with Collegium Pharmaceutical
Supporting Materials
Download Event Supporting Material Depomed Conference Call to Discuss NUCYNTA® Commercialization Agreement with Collegium Pharmaceutical
Download Event Supporting Material Depomed Conference Call to Discuss NUCYNTA® Commercialization Agreement with Collegium Pharmaceutical Transcript
11/28/17
8:30 a.m. ET
Depomed at Piper Jaffray Healthcare Conference
Location:New York, NY
11/07/17
4:30 p.m. ET
Q3 2017 Depomed Earnings Conference Call
Supporting Materials
Download Event Supporting Material Q3 2017 Depomed Earnings Presentation
Download Event Supporting Material Q3 2017 Depomed Earnings Conference Transcript
09/12/17
4:40 p.m. ET
Depomed at the Morgan Stanley Global Healthcare Conference
03/23/16
9:00 a.m. ET
Depomed Analyst and Investor Day

DEPO (Common Stock)

Exchange
NASDAQ CM
Price
$7.50
Change (%)
 + 0.09 (1.21%)
Volume
425,898
Market Cap
$472,600,883

Data as of 02/23/18 2:32 p.m. ET
Minimum 20 minute delay
Refresh quote
Powered By EDGAR Online, Inc.